• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2021 Jun 24;21(1):602.
doi: 10.1186/s12879-021-06300-7.
Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study


Jinghua Gao[SUP] #[/SUP][SUP] 1 2 [/SUP], Li Zhong[SUP] #[/SUP][SUP] 3 [/SUP], Ming Wu[SUP] 4 [/SUP], Jingjing Ji[SUP] 2 [/SUP], Zheying Liu[SUP] 2 [/SUP], Conglin Wang[SUP] 2 [/SUP], Qifeng Xie[SUP] 2 [/SUP], Zhifeng Liu[SUP] 5 6 7 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19) has spread around the world, until now, the number of positive and death cases is still increasing. Therefore, it remains important to identify risk factors for death in critically patients.
Methods: We collected demographic and clinical data on all severe inpatients with COVID-19. We used univariable and multivariable Cox regression methods to determine the independent risk factors related to likelihood of 28-day and 60-day survival, performing survival curve analysis.
Results: Of 325 patients enrolled in the study, Multi-factor Cox analysis showed increasing odds of in-hospital death associated with basic illness (hazard ratio
6.455, 95% Confidence Interval [CI] 1.658-25.139, P = 0.007), lymphopenia (HR 0.373, 95% CI 0.148-0.944, P = 0.037), higher Sequential Organ Failure Assessment (SOFA) score on admission (HR 1.171, 95% CI 1.013-1.354, P = 0.033) and being critically ill (HR 0.191, 95% CI 0.053-0.687, P = 0.011). Increasing 28-day and 60-day mortality, declining survival time and more serious inflammation and organ failure were associated with lymphocyte count < 0.8 × 109/L, SOFA score > 3, Acute Physiology and Chronic Health Evaluation II (APACHE II) score > 7, PaO2/FiO2 < 200 mmHg, IL-6 > 120 pg/ml, and CRP > 52 mg/L.
Conclusions: Being critically ill and lymphocyte count, SOFA score, APACHE II score, PaO2/FiO2, IL-6, and CRP on admission were associated with poor prognosis in COVID-19 patients.

Keywords: COVID-19; Mortality; Risk factors; SARS-COV-2.
 
Back
Top Bottom